BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 31474297)

  • 1. Analysis of the Liver Transplant Waiting List in Our Center.
    Emek E; Yesim Kara Z; Demircan FH; Serin A; Yazici P; Sahin T; Tokat Y; Bozkurt B
    Transplant Proc; 2019 Sep; 51(7):2413-2415. PubMed ID: 31474297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A method for establishing allocation equity among patients with and without hepatocellular carcinoma on a common liver transplant waiting list.
    Vitale A; Volk ML; De Feo TM; Burra P; Frigo AC; Ramirez Morales R; De Carlis L; Belli L; Colledan M; Fagiuoli S; Rossi G; Andorno E; Baccarani U; Regalia E; Vivarelli M; Donataccio M; Cillo U;
    J Hepatol; 2014 Feb; 60(2):290-7. PubMed ID: 24161408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Italian Score for Organ Allocation System on Deceased Donor Liver Transplantation: A Monocentric Competing Risk Time-to-Event Analysis.
    Khouzam S; Pagano D; Barbàra M; Cintorino D; Li Petri S; di Francesco F; Ricotta C; Bonsignore P; Seidita A; Calamia S; Canzonieri M; Tropea A; Gruttadauria S
    Transplant Proc; 2019 Nov; 51(9):2860-2864. PubMed ID: 31711575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. End-stage liver disease candidates at the highest model for end-stage liver disease scores have higher wait-list mortality than status-1A candidates.
    Sharma P; Schaubel DE; Gong Q; Guidinger M; Merion RM
    Hepatology; 2012 Jan; 55(1):192-8. PubMed ID: 21898487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes for liver transplant candidates listed with low model for end-stage liver disease score.
    Kwong AJ; Lai JC; Dodge JL; Roberts JP
    Liver Transpl; 2015 Nov; 21(11):1403-9. PubMed ID: 26289624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The race to liver transplantation: a comparison of patients with and without hepatocellular carcinoma from listing to post-transplantation.
    Patel MS; Kohn R; Kratz JR; Shah JA; Markmann JF; Vagefi PA
    J Am Coll Surg; 2015 Jun; 220(6):1001-7. PubMed ID: 25868408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver transplant recipient survival benefit with living donation in the model for endstage liver disease allocation era.
    Berg CL; Merion RM; Shearon TH; Olthoff KM; Brown RS; Baker TB; Everson GT; Hong JC; Terrault N; Hayashi PH; Fisher RA; Everhart JE
    Hepatology; 2011 Oct; 54(4):1313-21. PubMed ID: 21688284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HEPATOCELLULAR CARCINOMA PATIENTS ARE ADVANTAGED IN THE CURRENT BRAZILIAN LIVER TRANSPLANT ALLOCATION SYSTEM. A COMPETING RISK ANALYSIS.
    Rodríguez S; Fleck AM; Mucenic M; Marroni C; Brandão A
    Arq Gastroenterol; 2020; 57(1):19-23. PubMed ID: 32294731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proposal of a novel MELD exception point system for hepatocellular carcinoma based on tumor characteristics and dynamics.
    Bhat M; Ghali P; Dupont B; Hilzenrat R; Tazari M; Roy A; Chaudhury P; Alvarez F; Carrier M; Bilodeau M
    J Hepatol; 2017 Feb; 66(2):374-381. PubMed ID: 27751840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lower rates of receiving model for end-stage liver disease exception and longer time to transplant among nonalcoholic steatohepatitis hepatocellular carcinoma.
    Young K; Aguilar M; Gish R; Younossi Z; Saab S; Bhuket T; Liu B; Ahmed A; Wong RJ
    Liver Transpl; 2016 Oct; 22(10):1356-66. PubMed ID: 27348270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. End-stage liver disease patients with MELD >40 have higher waitlist mortality compared to Status 1A patients.
    Ahn J; Bhuket T; Mosadeghi S; Frenette C; Liu B; Wong RJ
    Hepatol Int; 2016 Sep; 10(5):838-46. PubMed ID: 27221700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver transplantation for T3 lesions has higher waiting list mortality but similar survival compared to T1 and T2 lesions.
    Schmitt TM; Kumer SC; Shah N; Argo CK; Northup PG
    Ann Hepatol; 2010; 9(4):390-6. PubMed ID: 21057157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increasing Liver Transplantation Wait-List Dropout for Hepatocellular Carcinoma With Widening Geographical Disparities: Implications for Organ Allocation.
    Mehta N; Dodge JL; Hirose R; Roberts JP; Yao FY
    Liver Transpl; 2018 Oct; 24(10):1346-1356. PubMed ID: 30067889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The association of pretransplant ferritin level with waiting list and post-transplant survival. Does ferritin actually predict outcome?
    Al-Freah MA; Kriese S; Foxton MR; Quaglia A; Bomford A; Heaton ND; O'Grady JG; Agarwal K; Wendon JA; Heneghan MA
    Transpl Int; 2013 Nov; 26(11):1070-9. PubMed ID: 24138201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Excess mortality on the liver transplant waiting list: unintended policy consequences and Model for End-Stage Liver Disease (MELD) inflation.
    Northup PG; Intagliata NM; Shah NL; Pelletier SJ; Berg CL; Argo CK
    Hepatology; 2015 Jan; 61(1):285-91. PubMed ID: 24995689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes utilizing imported liver grafts for recipients with hepatocellular carcinoma.
    Battula N; Reichman TW; Amiri Y; Carmody IC; Galliano G; Seal J; Bugeaud E; Bohorquez H; Bruce D; Cohen A; Loss GE
    Liver Transpl; 2017 Mar; 23(3):299-304. PubMed ID: 28026108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver Transplantation for Hepatic Epithelioid Hemangioendothelioma Is Facilitated by Exception Points With Acceptable Long-term Outcomes.
    Brahmbhatt M; Prenner S; Bittermann T
    Transplantation; 2020 Jun; 104(6):1187-1192. PubMed ID: 31577674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiofrequency ablation of hepatocellular carcinoma as bridge therapy to liver transplantation: A 10-year intention-to-treat analysis.
    Lee MW; Raman SS; Asvadi NH; Siripongsakun S; Hicks RM; Chen J; Worakitsitisatorn A; McWilliams J; Tong MJ; Finn RS; Agopian VG; Busuttil RW; Lu DSK
    Hepatology; 2017 Jun; 65(6):1979-1990. PubMed ID: 28170115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of Model for End-Stage Liver Disease (MELD) score in a liver transplantation waiting list.
    Ferraz-Neto BH; Hidalgo R; Thomé T; Melo VA; Lobue A; Zurstrassen MP; Moraes JM; Meira-Filho SP; Rezende MB; Fonseca LE; Pandullo FL; Soeiro FS; Afonso RC
    Transplant Proc; 2007 Oct; 39(8):2511-3. PubMed ID: 17954160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mortality Analysis of Acute Liver Failure in Uruguay.
    Mainardi V; Rando K; Olivari D; Rey G; Castelli J; Grecco G; Leites A; Harguindeguy M; Gerona S
    Transplant Proc; 2018 Mar; 50(2):465-471. PubMed ID: 29579829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.